Kapak Resmi

Study of the pharmacokinetics of antituberculosis drug Biomairin

Resume. The results of a studying the pharmacokinetics of the anti-tuberculosis drug Biomayrin in experimental animals (rats) after oral administration were presented. A comparative analysis of the pharmacokinetic parameters of Biomayrin with a comparing drug (a mixture of rifampicin, ethambutol and...

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Sh. A. Shomurotov (Yazar), E. M. Sultanova (Yazar), M. K. Salakhutdinova (Yazar), U. J. Ishimov (Yazar), J. F. Ziyavitdinov (Yazar), O. N. Veshkurova (Yazar), A. S. Turaev (Yazar)
Materyal Türü:	Kitap
Baskı/Yayın Bilgisi:	LLC "Publisher OKI", 2018-11-01T00:00:00Z.
Konular:	article
Online Erişim:	Connect to this object online.
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
Yazar:: B.B. MAYKANAEV, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
Yazar:: Louvina E. van der Laan, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
Yazar:: M. E. Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Antituberculosis drug-induced hepatotoxicity in children
Yazar:: Peter R. Donald
Baskı/Yayın Bilgisi: (2011)

Effectiveness of new antituberculosis drugs in the treatment of children and adolescents with chemoresistant tuberculosis
Yazar:: M.І. Sakhelashvili, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Combined antiretroviral and antituberculosis drug resistance following incarceration
Yazar:: Katharine Elizabeth Stott, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
Yazar:: Julia Bespyatykh, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Seizures following Intoxication with a Common Antituberculosis Drug
Yazar:: Adnane Lahlou, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Prevalence of Hepatotoxicity From Antituberculosis Therapy
Yazar:: Arunava Saha, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
Yazar:: Oymak Sema F, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

New antituberculosis drugs: from clinical trial to programmatic use
Yazar:: Gina Gualano, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
Yazar:: Mohd Khairul Nizam Mazlan, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

VITAMINS AS IMMUNOMODULATORS AND ANTITUBERCULOSIS TARGETS
Yazar:: Andreea-Daniela Meca, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors
Yazar:: Valeria V. Kleandrova, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

DETECTION OF DRUG ALLERGY ON ANTITUBERCULOSIS DRUGS USING LEUKOCYTES LYSIS SENSIBILIZATION REACTION AND TOTAL IMMUNOGLOBULIN E
Yazar:: E.V. DUDENKO, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
Yazar:: Quanxian Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities
Yazar:: Yuki Nishimura, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
Yazar:: Bina Akura, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review
Yazar:: Klaudia T. Angula, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

STUDY OF TECHNOLOGICAL PROPERTIES OF SUBSTANCE AND BASIC COMPOSITION FOR OBTAINING THE DRUG PRODUCT OF "BIOMAYRIN"
Yazar:: N. E. Mamatmusaeva, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

A Study of Embryotoxic, Foetotoxic, and Teratogenic Effects of the Original Antituberculosis Agent Thiozonide in Pregnant Rabbits
Yazar:: A. Yu. Borodina, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

A Working Plan for Colored Antituberculosis Leagues
Yazar:: Wertenbaker, Charles Poindexter, 1860-1916

Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
Yazar:: Maria Adriana Rangel, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Evaluation of therapeutic effectiveness of antituberculosis injection based on conversion time in drug-resistant tuberculosis
Yazar:: Emy Oktaviani, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
Yazar:: Qiang Su, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
Yazar:: Han YR, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Case Report: DRESS Syndrome Induced by Two Antituberculosis Drugs in an 8-Year-Old Girl
Yazar:: Vaidotas Urbonas, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Incidence of side effects of antituberculosis drugs and their related factors in northern Iran: a retrospective cohort study
Yazar:: Kheradmand, Motahareh, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Kleinhovia hospita extract alleviates experimental hepatic and renal toxicities induced by a combination of antituberculosis drugs
Yazar:: Yulia Yusrini Djabir, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Tuberculous ulcer of tongue with oral complications of oral antituberculosis therapy
Yazar:: Ajay G, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment
Yazar:: Marlene Knight, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Syntheses and evaluation of multicaulin and miltirone-like compounds as antituberculosis agents
Yazar:: Serdar Burmaoğlu, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates
Yazar:: Prabasiwi Nur Fauziyah, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis L,D-transpeptidase 2
Yazar:: Billones JB, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age
Yazar:: Maria Goretti López-Ramos, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

The Chemical Components of <em>Sesbania grandiflora</em> Root and Their Antituberculosis Activity
Yazar:: Anis Safirah Mohd Zahariluddin, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations
Yazar:: Vinícius de S. Pinto, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Acceptance of an Informational Antituberculosis Chatbot Among Korean Adults: Mixed Methods Research
Yazar:: Agnes Jihae Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
Yazar:: Pitaloka DAE, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

IMPACT OF LIMITED ORAL ANTITUBERCULOSIS INFORMATION TO THE TUBERCULOSIS PATIENTS' COMPLIANCE AND THEIR QUALITY OF LIFE
Yazar:: Dian Handayani, ve diğerleri
Baskı/Yayın Bilgisi: (2013)